SRC and cancer: Clinical trials targeting Src in OC have not found an improvement in patient outcome; but the OC trials reported to date did not select patients based on Src expression.19, 20, 21 Future trials involving only patients with tumors exhibiting active Src signaling will be required to fully evaluate whether inhibiting Src can offer a survival benefit for OC patients with Src-driven cancers.